Invesco’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.5M Sell
479,399
-145,466
-23% -$3.48M ﹤0.01% 1695
2025
Q1
$15.5M Buy
624,865
+384,419
+160% +$9.55M ﹤0.01% 1557
2024
Q4
$4.53M Sell
240,446
-683,699
-74% -$12.9M ﹤0.01% 2295
2024
Q3
$13.9M Buy
924,145
+375,538
+68% +$5.65M ﹤0.01% 1660
2024
Q2
$15.7M Sell
548,607
-2,052
-0.4% -$58.7K ﹤0.01% 1542
2024
Q1
$16.1M Buy
550,659
+71,065
+15% +$2.08M ﹤0.01% 1552
2023
Q4
$16.2M Sell
479,594
-435,113
-48% -$14.7M ﹤0.01% 1529
2023
Q3
$28.1M Sell
914,707
-470,177
-34% -$14.4M 0.01% 1192
2023
Q2
$55.5M Sell
1,384,884
-13,602
-1% -$545K 0.01% 908
2023
Q1
$57.1M Buy
1,398,486
+37,853
+3% +$1.54M 0.02% 895
2022
Q4
$52.5M Buy
1,360,633
+217,664
+19% +$8.4M 0.02% 915
2022
Q3
$60.8M Buy
1,142,969
+54,228
+5% +$2.88M 0.02% 829
2022
Q2
$63.5M Buy
1,088,741
+716,018
+192% +$41.7M 0.02% 840
2022
Q1
$28.4M Sell
372,723
-98,643
-21% -$7.53M 0.01% 1275
2021
Q4
$28.4M Sell
471,366
-68,138
-13% -$4.1M 0.01% 1324
2021
Q3
$30.2M Buy
539,504
+85,413
+19% +$4.78M 0.01% 1302
2021
Q2
$27.6M Sell
454,091
-100,599
-18% -$6.1M 0.01% 1403
2021
Q1
$38.9M Sell
554,690
-49,865
-8% -$3.5M 0.01% 1179
2020
Q4
$36.2M Sell
604,555
-481
-0.1% -$28.8K 0.01% 1145
2020
Q3
$36.4M Sell
605,036
-67,008
-10% -$4.03M 0.01% 1050
2020
Q2
$35.3M Buy
672,044
+223,137
+50% +$11.7M 0.01% 1053
2020
Q1
$15.1M Sell
448,907
-161,445
-26% -$5.41M 0.01% 1330
2019
Q4
$27.6M Buy
610,352
+380,422
+165% +$17.2M 0.01% 1243
2019
Q3
$8.75M Sell
229,930
-80,849
-26% -$3.08M ﹤0.01% 1805
2019
Q2
$13.5M Sell
310,779
-86,362
-22% -$3.76M ﹤0.01% 1621
2019
Q1
$15.1M Buy
397,141
+24,225
+6% +$922K 0.01% 1379
2018
Q4
$16M Sell
372,916
-49,152
-12% -$2.11M 0.01% 1256
2018
Q3
$20.7M Buy
422,068
+391,991
+1,303% +$19.3M 0.01% 1255
2018
Q2
$964K Sell
30,077
-130,775
-81% -$4.19M ﹤0.01% 3151
2018
Q1
$5.01M Sell
160,852
-490,792
-75% -$15.3M ﹤0.01% 1949
2017
Q4
$29.7M Sell
651,644
-14,532
-2% -$663K 0.01% 993
2017
Q3
$25M Sell
666,176
-5,055
-0.8% -$190K 0.01% 1090
2017
Q2
$32M Sell
671,231
-9,672
-1% -$461K 0.01% 984
2017
Q1
$31.1M Buy
680,903
+7,166
+1% +$327K 0.01% 1005
2016
Q4
$21.8M Buy
673,737
+133,332
+25% +$4.31M 0.01% 1122
2016
Q3
$18.5M Buy
540,405
+1,549
+0.3% +$53K 0.01% 1181
2016
Q2
$18.2M Sell
538,856
-274,402
-34% -$9.26M 0.01% 1174
2016
Q1
$43.1M Sell
813,258
-67,916
-8% -$3.6M 0.02% 815
2015
Q4
$67.7M Sell
881,174
-32,105
-4% -$2.47M 0.03% 649
2015
Q3
$37.5M Sell
913,279
-465,807
-34% -$19.1M 0.02% 873
2015
Q2
$97.5M Buy
1,379,086
+208,499
+18% +$14.7M 0.04% 522
2015
Q1
$104M Sell
1,170,587
-33,299
-3% -$2.96M 0.04% 503
2014
Q4
$107M Buy
1,203,886
+466,224
+63% +$41.3M 0.04% 495
2014
Q3
$71.5M Buy
737,662
+110,248
+18% +$10.7M 0.03% 620
2014
Q2
$57.6M Buy
627,414
+500,092
+393% +$45.9M 0.02% 732
2014
Q1
$8.91M Buy
127,322
+76,353
+150% +$5.34M ﹤0.01% 1578
2013
Q4
$2.93M Sell
50,969
-9,945
-16% -$572K ﹤0.01% 2402
2013
Q3
$2.93M Buy
60,914
+43,450
+249% +$2.09M ﹤0.01% 2287
2013
Q2
$506K Buy
+17,464
New +$506K ﹤0.01% 3268